We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FHI icon
776
Federated Hermes
FHI
$4.74B
$217K 0.02%
4,895
-297
-6% -$12.2K
CPB icon
777
Campbell Soup
CPB
$6.83B
$217K 0.02%
+7,075
New +$249K
QFIN icon
778
Qfin Holdings
QFIN
$1.56B
$217K 0.02%
5,000
-5,010
-50% -$209K
BPOP icon
779
Popular Inc
BPOP
$11.2B
$216K 0.02%
+1,960
New +$194K
LEA icon
780
Lear
LEA
$8.03B
$216K 0.02%
2,274
-1,413
-38% -$124K
AAPL icon
781
Apple
AAPL
$4.48T
$215K 0.02%
1,050
-2,743
-72% -$554K
AZO icon
782
AutoZone
AZO
$50.4B
$215K 0.02%
58
-83
-59% -$306K
XRAY icon
783
Dentsply Sirona
XRAY
$2.38B
$215K 0.02%
+13,538
New +$202K
AIOT
784
PowerFleet Inc
AIOT
$434M
$215K 0.02%
49,868
+4,497
+10% +$22.2K
PATH icon
785
UiPath
PATH
$7.75B
$214K 0.02%
+16,734
New +$201K
AQST icon
786
Aquestive Therapeutics
AQST
$571M
$214K 0.02%
64,702
+16,361
+34% +$46.9K
NATL icon
787
NCR Atleos
NATL
$3.42B
$214K 0.02%
+7,500
New +$202K
ARQT icon
788
Arcutis Biotherapeutics
ARQT
$3.2B
$213K 0.02%
15,203
-7,882
-34% -$110K
SE icon
789
PUT
Sea Limited
SE
$70.2B
$213K 0.02%
195
-17,705
-99% -$2.56M
ACM icon
790
Aecom
ACM
$9.86B
$212K 0.02%
+1,875
New +$195K
AMRZ
791
Amrize Ltd
AMRZ
$26.2B
$211K 0.02%
+4,265
New +$215K
ODP
792
DELISTED
ODP
ODP
$211K 0.02%
+11,646
New +$183K
ENVX icon
793
Enovix
ENVX
$1.04B
$211K 0.02%
23,306
+6,225
+36% +$40.6K
LDOS icon
794
Leidos
LDOS
$17.4B
$210K 0.02%
1,331
-1,183
-47% -$175K
MET icon
795
MetLife
MET
$62.1B
$209K 0.02%
2,604
-355
-12% -$27.4K
PNC icon
796
PNC Financial Services
PNC
$101B
$208K 0.02%
1,118
-636
-36% -$108K
DHR icon
797
Danaher
DHR
$144B
$208K 0.02%
+1,055
New +$205K
EXPD icon
798
Expeditors International
EXPD
$23.3B
$208K 0.02%
+1,822
New +$204K
APTV icon
799
Aptiv
APTV
$10.1B
$208K 0.02%
+3,043
New +$188K
EXE
800
Expand Energy Corp
EXE
$22B
$207K 0.02%
+1,772
New +$198K
30 31
32
33 34

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.